We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures to a variety of diseases. By attacking the disease directly with our novel TIMP/IMP technology and working strategically with our medical and scientific partners we seek to provide treatments and cures previously unavailable to doctors and their patients.


John. J. Puisis

Co-Founder, President and Chief Executive Officer

Jim Herrmann

Co-founder, Chief Operating and Chief Financial Officer

Daniel R. Getts, PHD

Co-Founder, Chief Scientific Officer

Jill Heady

Vice President of Finance and Administration

Frank Fokta, PHD

Director of Quality Assurance

Olga Jasinsky

Director of Operations

Mary Beth Holum

Director of Clinical Operations

Joseph Podojil, PHD

Senior Scientist

Ryan Pearson, PHD

Scientist I – Polymer

Sam Magnuson

Business Analyst

Linda Boerema

Office Administration


Ciaran P. Kelly, MD

Harvard Medical School

Nick King, MD, PHD

University of Sydney Australia

Stephen D. Miller, PHD

Northwestern University

Roy First, MD

Cour Pharmaceuticals

Kari Nadeau, MD, PHD

Stanford University

Lonnie D. Shea, PHD

University of Michigan